This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Flora J. Keumurian
Advertisement
Flora J. Keumurian, florak@mit.edu, is program and operations manager, MIT Center for Biomedical Innovation.
Articles by Flora J. Keumurian
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsPublished: August 4th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
Why Sound Science Is Pharma's Best Defense Against Regulatory Shifts
5
